Wuhan Keqian Biology Co. Ltd. Class ASSE: 688526

"Wuhan Keqian Biology Co., Ltd."Announcement on Voluntary Disclosure of Obtaining New Veterinary Drug Registration Certificate

Jul 31, 2026 · Issued by Wuhan Keqian Biology Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Voluntary Disclosure of Obtaining New Veterinary Drug Registration Certificate

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Wuhan Keqian Biology Co. Ltd. Class A

"Wuhan Keqian Biology Co., Ltd."Announcement on Voluntary Disclosure of Planned Signing of Cooperative R&D Agreements with Huazhong Agricultural University and Liaoning Animal Disease Prevention and Control Center and Related Party TransactionsJul 15
"Wuhan Keqian Biology Co.,Ltd"Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction and 2025 Annual Performance BriefingJul 2
Announcement on Implementation of Dividend Distribution for 2025May 20
Announcement on 2025 Annual and Q1 2026 Performance and Cash Dividend BriefingMay 1

All Wuhan Keqian Biology Co. Ltd. Class A news releases